Do urinary mycotoxin tests only show recent exposure or excretion?

Urinary mycotoxin testing is best understood as a limited exposure biomarker, not a diagnostic test for “mycotoxin illness,” a measure of body stores, or a means of identifying a building or other source. This distinction is particularly important when symptoms are nonspecific or when a result is used to support major environmental or medical decisions.

What a positive urine result means

• A valid measurement of a mycotoxin or metabolite shows urinary excretion at or near specimen collection and generally supports recent exposure. Dietary intake is a principal route; controlled human data indicate urinary deoxynivalenol (DON) can reflect intake over approximately 24–48 hours.
• Quantitative interpretation is toxin- and method-specific. Spot-urine results are affected by sampling time and urine dilution; 24-hour or timed collections better represent total excretion. Creatinine adjustment can address dilution but does not establish dose, clinical significance, or assay validity.

Source and body-burden interpretation

• Urine cannot distinguish food-associated exposure from occupational, inhalational, dermal, or indoor-environmental exposure. Organic-dust work (eg, grain handling, farming, baking, waste work) may add exposure, but a urine result cannot identify the route independently.
• A urine concentration is not a tissue-burden measurement. Excretion is often short-term and variable, and there are no validated clinically meaningful urine-to-tissue correlations. Low urinary recovery for some toxins, such as fumonisin B1, further limits inference.

Symptoms and clinical implications

• Healthy people may excrete mycotoxins, often after ordinary dietary exposure. No validated urinary threshold predicts illness, and CDC/ACMT-cited guidance indicates that positive urine results do not establish disease, causation, or water-damaged-building exposure.
• Symptom attribution requires conventional clinical assessment, alternative-diagnosis evaluation, and independently corroborated exposure evidence.

Bottom line

• Urinary mycotoxin detection can support recent excretion/exposure, but alone cannot establish source, cumulative tissue burden, or that the detected toxin caused a patient’s symptoms.